Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

Theranostics. 2022 Feb 7;12(5):2150-2161. doi: 10.7150/thno.64252. eCollection 2022.

Abstract

Background: Platelets are active players in tumorigenesis, although the exact interactive mechanisms and their direct impact on tumor cells remain largely unknown. Methods: Bidirectional transference of lipids, proteins and RNA between platelets and tumor cells and its impact on tumor cell behavior and tumor process are analyzed in this work. Phenotypic, genetic and functional modifications induced by platelets were analyzed both in tumor cell lines and in circulating tumor cells (CTCs). Results: Data from these assays showed that platelets transferred structural components to tumor cells with higher efficiency than tumor cells to platelets (p = 0.001). This biological interplay occurred by direct contact, internalization or via extracellular vesicles. As a result, tumor cells acquired platelet markers (CD61 and CD42), showed decreased EpCAM, expressed epithelial-to-mesenchymal transition markers, and increased proliferation rates. Moreover, we were able to detect CD61 in CTCs from early and advanced prostate cancer. Conclusions: Our results demonstrated, for the first time, that platelets educate tumor cells by highly efficient transference of lipids, proteins and RNA through different mechanisms. These results suggest that tumor cells and CTCs might acquire highly dynamic and aggressive phenotypes due to platelets interaction including EMT, stem-like phenotype and high proliferative rates.

Keywords: CD61; Platelets; circulating tumor cells (CTCs); epithelial-to-mesenchymal transition (EMT); platelet-educated tumors (PETs).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Blood Platelets* / metabolism
  • Cell Line, Tumor
  • Humans
  • Lipids
  • Male
  • Neoplastic Cells, Circulating* / metabolism
  • RNA

Substances

  • Biomarkers, Tumor
  • Lipids
  • RNA